Dennis C. Sgroi

Massachusetts General Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

97h-index47.9kcitations433works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(110), Cancer Genomics and Diagnostics(57), Estrogen and related hormone effects(56), Advanced Breast Cancer Therapies(49), Breast Lesions and Carcinomas(32)

Publications386 total

ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings
2025Open Access
Abstract P2-06-13: HOXB13 Expression Induces an Immunosuppressive Tumor Microenvironment in Breast Cancer
Clinical Cancer Research·2025
Abstract 7472: Metabolic mechanisms underlying late recurrence in hormone receptor positive breast cancer
Cancer Research·2025
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Breast Cancer Research·2024· 2 citedOpen Access
Table S2 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Figure S5 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Figure S1 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Figure S6 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Figure S2 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Figure S4 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Table S1 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Figure S3 from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Data from Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
2024Open Access
Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea
New England Journal of Medicine·2024
<i>ERBB2</i> / <i>HOXB13</i> co-amplification with interstitial deletion of <i>BRCA1</i> defines a unique subset of breast cancers
2024Open Access
Abstract PO5-01-11: Breast Cancer Index and comparative analysis of late distant recurrence risk with results from the TEAM trial
Cancer Research·2024
Supplementary Figure S1 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial
2024Open Access
Supplementary Table from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial
2024Open Access
Data from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial
2024Open Access
Supplementary Figure S1 from Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial
2024Open Access
page 1 of 20Next →

Frequent Co-authors

Daniel A. Haber(10), Mark G. Erlander(10), Daphne W. Bell(6), Beth Muir(5), Ranelle Salunga(5), Xiaojun Ma(5), Shyamala Maheswaran(4), Gad Getz(4), Leif W. Ellisen(4), Barbara L. Smith(4), A. John Iafrate(4), Maria J. Merino(4), Catherine A. Schnabel(4), Min Yu(3), Aditya Bardia(3), Ben S. Wittner(3), David T. Ting(3), Steven J. Isakoff(3), Sridhar Ramaswamy(3), Mehmet Toner(3)